Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)
Bangladesh
· Delayed Price · Currency is BDT
136.50
+6.70 (5.16%)
At close: Dec 19, 2024
Beacon Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Cash & Equivalents | 323.21 | 306.95 | 452.19 | 538.5 | 337.84 | 598.78 | Upgrade
|
Short-Term Investments | 3,044 | 15.36 | 26.33 | 6.16 | 5.87 | 14.67 | Upgrade
|
Cash & Short-Term Investments | 3,368 | 322.32 | 478.52 | 544.66 | 343.71 | 613.45 | Upgrade
|
Cash Growth | 1216.75% | -32.64% | -12.14% | 58.46% | -43.97% | 106.90% | Upgrade
|
Accounts Receivable | 2,992 | 2,758 | 2,081 | 1,964 | 1,933 | 1,060 | Upgrade
|
Other Receivables | - | 224.79 | 134.55 | - | - | 168.99 | Upgrade
|
Receivables | 2,992 | 5,610 | 4,947 | 2,486 | 2,337 | 1,229 | Upgrade
|
Inventory | 2,689 | 2,888 | 1,992 | 1,972 | 1,279 | 1,033 | Upgrade
|
Other Current Assets | 4,385 | 3,897 | 1,566 | 1,301 | 1,016 | 605.59 | Upgrade
|
Total Current Assets | 13,433 | 12,717 | 8,983 | 6,444 | 5,216 | 3,786 | Upgrade
|
Property, Plant & Equipment | 6,131 | 6,187 | 5,648 | 4,371 | 3,319 | 3,391 | Upgrade
|
Long-Term Investments | - | - | - | 1.03 | 0.87 | 0.63 | Upgrade
|
Other Intangible Assets | 24.55 | 27.98 | 10.79 | - | - | - | Upgrade
|
Other Long-Term Assets | - | - | - | - | 0 | - | Upgrade
|
Total Assets | 19,589 | 18,932 | 14,642 | 10,816 | 8,536 | 7,177 | Upgrade
|
Accounts Payable | 1,686 | 905.7 | 297.45 | 32.51 | 113.67 | -27.09 | Upgrade
|
Accrued Expenses | - | 310.19 | 209.52 | 448.83 | 354.26 | 232.32 | Upgrade
|
Short-Term Debt | 6,309 | 6,699 | 6,500 | 3,413 | 1,884 | 1,535 | Upgrade
|
Current Portion of Long-Term Debt | 979.3 | 891.43 | 182.55 | 216.01 | 225.9 | 153.89 | Upgrade
|
Current Income Taxes Payable | 347.86 | 246.13 | 79.54 | 258.59 | -18.65 | - | Upgrade
|
Other Current Liabilities | 28.01 | 209.71 | 220.88 | 305.13 | 233.92 | 159.91 | Upgrade
|
Total Current Liabilities | 9,350 | 9,262 | 7,490 | 4,674 | 2,793 | 2,054 | Upgrade
|
Long-Term Debt | 2,918 | 2,729 | 772.48 | 197.91 | 387.75 | 493.02 | Upgrade
|
Long-Term Deferred Tax Liabilities | 161.9 | 176.57 | 113.44 | - | - | - | Upgrade
|
Total Liabilities | 13,138 | 12,841 | 8,700 | 4,872 | 3,180 | 2,547 | Upgrade
|
Common Stock | 2,310 | 2,310 | 2,310 | 2,310 | 2,310 | 2,310 | Upgrade
|
Retained Earnings | 3,297 | 2,892 | 2,565 | 2,404 | 1,639 | 738.74 | Upgrade
|
Comprehensive Income & Other | 844.33 | 888.6 | 1,067 | 1,229 | 1,406 | 1,582 | Upgrade
|
Shareholders' Equity | 6,451 | 6,090 | 5,942 | 5,944 | 5,355 | 4,630 | Upgrade
|
Total Liabilities & Equity | 19,589 | 18,932 | 14,642 | 10,816 | 8,536 | 7,177 | Upgrade
|
Total Debt | 10,206 | 10,319 | 7,455 | 3,827 | 2,497 | 2,181 | Upgrade
|
Net Cash (Debt) | -6,838 | -9,997 | -6,977 | -3,282 | -2,153 | -1,568 | Upgrade
|
Net Cash Per Share | -29.60 | -43.28 | -30.20 | -14.21 | -9.32 | -6.79 | Upgrade
|
Filing Date Shares Outstanding | 231 | 231 | 231 | 231 | 231 | 231 | Upgrade
|
Total Common Shares Outstanding | 231 | 231 | 231 | 231 | 231 | 231 | Upgrade
|
Working Capital | 4,083 | 3,455 | 1,493 | 1,770 | 2,423 | 1,732 | Upgrade
|
Book Value Per Share | 27.93 | 26.37 | 25.72 | 25.73 | 23.18 | 20.04 | Upgrade
|
Tangible Book Value | 6,426 | 6,062 | 5,931 | 5,944 | 5,355 | 4,630 | Upgrade
|
Tangible Book Value Per Share | 27.82 | 26.24 | 25.68 | 25.73 | 23.18 | 20.04 | Upgrade
|
Land | - | 663.81 | 657.98 | 624.1 | 566.06 | 566.06 | Upgrade
|
Buildings | - | 2,208 | 1,083 | 978.41 | 978.41 | 978.41 | Upgrade
|
Machinery | - | 4,745 | 4,014 | 3,031 | 2,465 | 2,270 | Upgrade
|
Construction In Progress | - | 1,130 | 1,957 | 1,299 | 437.22 | 342.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.